Replies to post #329520 on Amarin Corp Plc (AMRN)

[north40000]

Your opinion is accurate; the CNBC publication was 3 years ago. Are there human clinical trials using the cited compound in process?

[HDGabor]

r-

Obviously this is light years away

But the expected completion of the CLEAR study (an event-driven*, global, randomized, double-blind, placebo-controlled study that completed enrollment in August 2019 of 14,032 patients with hypercholesterolemia and high CVD risk at over 1,400 sites in 32 countries) is 2022 H2.

* occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease (CVD) who are only able to tolerate less than the lowest approved daily starting dose of a statin and are considered “statin averse.”

Best,
G

[Jasbg]

rose@ Every second week (or third or fourth) a new cure for cancer (ready possibly 10 years from now) announced 'before Covid' for the last decades.

As far as I noticed it was a University study (not one of the big BP's)

As of now I wouldn't lose any sleep over it (for this one).
--------------------

I 100% agrees with you generally - in 'Not Wise Slow-Walking' - entry of any new product in the markets' - including Vascepa (Vazkepa).

Competition is always there' - and can 'Eat you at any Moment' - if you don't MOVE on every chance Given :)

Jasbg